OPKO HEALTH, INC.

OPKO HEALTH, INC.

OPKO Health, Inc., a healthcare company, engages in the diagnostics and pharmaceuticals businesses in the United States, Ireland, Chile, Spain, Israel, Mexico, and internationally. The company's Diagnostics segment operates BioReference Laboratories that offers laboratory testing services for the detection, diagnosis, evaluation, monitoring, and treatment of diseases, including esoteric testing, molecular diagnostics, anatomical pathology, genetics, women's health, and correctional healthcare to... physician offices, clinics, hospitals, employers and governmental units, as well as 4Kscore prostate cancer testing services. The company's Pharmaceutical segment offers Rayaldee for treatment for secondary hyperparathyroidism in adults with stage 3 or 4 chronic kidney disease, and vitamin D insufficiency; OPK88004, an orally administered selective androgen receptor modulator; OPK88003, a once-weekly administered peptide for the treatment of type 2 diabetes and associated obesity that is in Phase IIb trials; and hGH-CTP, a once-weekly human growth hormone injection that completed Phase III clinical trial in partnership with Pfizer, Inc. This segment develops and commercializes longer-acting proprietary versions of already approved therapeutic proteins. It also specialty active pharmaceutical ingredients; develops, manufactures, markets, and sells pharmaceutical, nutraceutical, veterinary, and ophthalmic products; commercializes food supplements and over the counter products; manufactures and sells products primarily in the generics market; and imports, markets, distributes, and sells pharmaceutical products in a range of indications, including cardiovascular products, vaccines, antibiotics, gastro-intestinal products, hormones, and others. In addition, the company operates pharmaceutical platforms in Ireland, Chile, Spain, and Mexico. OPKO Health, Inc. was incorporated in 1991 and is headquartered in Miami, Florida.

Opko Health, Inc._logo

Industry:
Company

Founded:
2007

Address:
4400 Biscayne Boulevard, Miami, FL, United States Zipcode 33137

Country:
Mexico

Phone:
305 575 4100

Company Size Range:
201 - 500
Current Employees:
215
Total Employees:
387

Market Cap:
58.06B
Total Revenue:
1.44B
Total Assets:
2.47B
Total Cash:
72.21M

Number of employees: 6,096


Key Executives
Name Title Pay Year Born
Dr. Phillip Frost Chairman & CEO 971,200$ 1936(84 years old)
Dr. Jane H. Hsiao M.B.A., Ph.D., MBA Vice Chairman & Chief Technical Officer 911,200$ 1947(73 years old)
Mr. Adam E. Logal Sr. VP & CFO 611,200$ 1978(42 years old)
Mr. Steven D. Rubin Exec. VP of Admin. & Director 821,200$ 1960(60 years old)
Dr. Arie Gutman Pres of API N/A 1954(66 years old)
Mr. James DeMarco Sr. VP of Pharmaceutical Sales N/A N/A
Mr. Thomas Nusbickel Chief Commercial Officer N/A N/A
Dr. Akhtar Ashfaq Sr. VP of Clinical R&D and Medical Affairs N/A N/A
Dr. Jon R. Cohen Sr. VP & Director N/A 1955(65 years old)
Ms. Jane Pine Wood J.D., Esq. Chief Legal Officer of Bio-Reference Laboratories N/A 1963(57 years old)



Financial & Stock
Company's stock symbol is OPK.MX. Lastest price : 86.00. Total volume :167.00 Click reload if you want to check the lastest price on market!!!


Site Inspections: http://www.opko.com

  • Host name: ec2-174-129-30-187.compute-1.amazonaws.com
  • IP address: 174.129.30.187
  • Location: Ashburn United States
  • Latitude: 39.0481
  • Longitude: -77.4728
  • Metro Code: 511
  • Timezone: America/New_York
  • Postal: 20149

Loading ...
Loading ...


More informations about "Opko Health, Inc." on Search Engine

OPKO Health, Inc. (OPK)

Opko.com A Diverse Healthcare Company Focused on Improving Patient Lives At OPKO Health, we seek to serve unmet patient needs through our first in class products, comprehensive diagnostics laboratories, robust research and development pipeline, and unique pharmaceutical business solutions. Who We …

OPKO Health, Inc. (OPK)

Opko.com Who We Are :: OPKO Health, Inc. (OPK)

OPKO Health, Inc. (OPK)

Opko.com SEC Filings :: OPKO Health, Inc. (OPK)

OPKO Health, Inc. (OPK)

Opko.com News / Events :: OPKO Health, Inc. (OPK)

OPKO Health, Inc. (OPK)

Opko.com Careers :: OPKO Health, Inc. (OPK). OPKO Health, Inc. is a diversified healthcare …

OPKO Health, Inc. (OPK)

Opko.com What We Do :: OPKO Health, Inc. (OPK)

OPKO Health, Inc. (OPK)

Opko.com Management Team :: OPKO Health, Inc. (OPK)

OPKO Health, Inc. (OPK)

Opko.com Contact :: OPKO Health, Inc. (OPK). OPKO Health, Inc. is a diversified healthcare …

Opko Health, Inc. (OPK) Stock Price, News, Quote & History

Finance.yahoo.com OPKO Health Inc (NASDAQ:OPK) was trading 3.4% higher from the previous closing price. A Form 4 filing filed with the SEC on Monday, March 8 showed that & Chairman Frost Phillip Md Et Al bought...

OPKO Health - Wikipedia

En.wikipedia.org OPKO Health is a medical test and medication company focused on diagnostics and pharmaceuticals. The company is a publicly traded company on NASDAQ and TASE under the symbol "OPK".

OPK Stock Price | OPKO Health Inc. Stock Quote (U.S)

Marketwatch.com OPKO Health Inc. OPKO Health, Inc., is a biopharmaceutical and diagnostics company, which engages in the provision of healthcare services. It operates through the following segments: Diagnostics...

OPKO Health Inc. [OPK] Revenue clocked in at $1.44 billion

Dbtnews.com Mar 27, 2021 · OPKO Health, Inc. (NASDAQ: OPK) reports business highlights and financial results for the three months ended December 31, 2020. It opened the trading session at $4.28, the shares rose to $4.55 and dropped to $4.245, the range by which the price of stock traded the whole day.

OPK Opko Health, Inc. — Stock Price and Discussion

Stocktwits.com Apr 13, 2021 · Opko Health, Inc. NYSEMkt Updated Apr 13, 2021 11:00 PM OPK 4.13 0.07 (1.72%). Post-Market 0.00 (0.00%)

OPKO Health, Inc. (NASDAQ:OPK) Could Soar to Much Higher

Marketingsentinel.com Mar 08, 2021 · OPKO Health, Inc. (NASDAQ:OPK)’s Major holders. If we look at who the major shareholders are, we find that insiders hold 40.08% of OPKO Health, Inc. shares while 30.38% of the shares are in the hands of institutional holders. The share float …

Sian Capital Urges OPKO Health to Address Apparently

Marketwatch.com Jan 13, 2021 · NEW YORK, Jan 13, 2021 (GLOBE NEWSWIRE via COMTEX) -- NEW YORK, Jan. 13, 2021 (GLOBE NEWSWIRE) -- Sian Capital, LLC (together with its affiliates, "Sian" or "we"), a sizable stockholder of OPKO...

Home | Steinberg v. Opko Health, Inc.

Opkohealthsecuritieslitigation.com Opko Health, Inc. Settlement Website The information contained on this website is only a summary of the information presented in more detail in the Notice of (I) Pendency of Class Action and Proposed Settlement; (II) Settlement Fairness Hearing; and (III) Motion for an Award of Attorneys’ Fees and Litigation Expenses.

OPKO Health, Inc.'s (OPK) CEO Phillip Frost on Q4 2020

Seekingalpha.com Feb 19, 2021 · OPKO Health, Inc. (NASDAQ:OPK) Q4 2020 Earnings Conference Call February 18, 2021 4:30 PM ET Company Participants. Yvonne Briggs - LHA IR. Phillip Frost - Chairman and CEO. Steven Rubin - EVP. Jon ...

Wall Street Analyst Initiated OPKO Health Inc. [OPK]. What

Dbtnews.com 2 days ago · OPKO Health Inc. [NASDAQ: OPK] closed the trading session at $4.32 on 04/15/21. The day’s price range saw the stock hit a low of $4.205, while the highest price level was $4.42. The company report on April 1, 2021 that BioReference Laboratories Expands Its …

Home - OPKO Health, Inc., Renal Division

Opkorenal.com OPKO Health Initiates Clinical Trial of RAYALDEE in COVID-19 Patients September 15, 2020. FDA Authorizes OPKO Health Clinical Trial Evaluating RAYALDEE in COVID-19 Patients June 01, 2020. OPKO Health Reports Interim Results for Two Ongoing RAYALDEE Studies March 25, 2020

Why Is Everyone Talking About OPKO Health Stock? | The

Fool.com Apr 16, 2020 · OPKO Health, Inc. NASDAQ: OPK $4.13 up $0.07 (1.72%) Related Articles. Here's Why OPKO Health's Solid Q4 Results Didn't Send Shares Flying Higher; Opko Health …

OPKO Health Inc. (OPK) and the Battle of Fundamentals vs

Newsheater.com Apr 13, 2021 · OPKO Health Inc. (NASDAQ:OPK) went down by -2.87% from its latest closing price compared to the recent 1-year high of $6.47. The company’s stock price has collected -10.77% of loss in the last five trading sessions. Press Release reported on 04/01/21 that BioReference Laboratories Expands Its Major League Sports Relationships with Addition of Major League Baseball

OPKO HEALTH INC (OPK.TA) Stock Price, News, Quote

Finance.yahoo.com OPKO Health Inc (NASDAQ:OPK) was trading 3.4% higher from the previous closing price. A Form 4 filing filed with the SEC on Monday, March 8 showed that & Chairman Frost Phillip Md Et Al bought...

OPKO Health, Inc. (NASDAQ:OPK) Could Have Exceptional

Marketingsentinel.com Mar 15, 2021 · OPKO Health, Inc. share prices are performing particularly well compared to other companies within the same industry. As is evident from the statistics, the company’s shares have risen +45.1 percent over the past six months and at a 100% annual growth rate that is well above the industry average of 21.8%.

OPKO Health Inc. settles class action suit for $16.5 million

Miamiherald.com Miami-based OPKO Health Inc. has agreed to settle a class action suit alleging a “pump and dump” stock fraud scheme for $16.5 million. The company, helmed by local philanthropist and ...

Opko Health, Inc. Company Profile | Miami, FL

Dnb.com OPKO Health operates clinical laboratories and develops tests and medicines for a range of health indications. The company's BioReference Laboratories unit is one of the largest clinical lab groups in the US. The subsidiary offers routine and esoteric services including, molecular diagnostics, oncology, women's health, and genetic testing.

Opko Health Inc. (OPK : NASDAQ) Stock Price & News

Google.com OPKO Health is a medical test and medication company focused on diagnostics and pharmaceuticals. The company is a publicly traded company on NASDAQ and TASE under the symbol "OPK".

Opko Health, Inc. - OPK - Stock Price Today - Zacks

Zacks.com Apr 13, 2021 · View OPKO Health, Inc. OPK investment & stock information. Get the latest OPKO Health, Inc. OPK detailed stock quotes, stock data, Real-Time ECN, charts, stats and more.

OPKO Health, Inc. (OPK) CEO Phil Frost on Q3 2020 Results

Seekingalpha.com OPKO Health, Inc. (NASDAQ:OPK) Q2 2020 Earnings Conference Call October 29, 2020, 04:30 PM ET Company Participants Yvonne Briggs - LHA Investor Relations Phil Frost - Chairman and Chief...

OPK | OPKO Health Inc. Stock Price & News - WSJ

Wsj.com News OPKO Health Inc.OPK. Opko Health Will Test the NFL for Coronavirus. The Stock Is Jumping. The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's ...

Opko Health Inc Stock Quote: OPK Stock News, Quotes

Research.investors.com Opko Health Inc (OPK) - DEVELOPS A BROAD RANGE OF PHARMACEUTICAL PRODUCTS, DIAGNOSTIC TESTS, AND VACCINES.

OPKO Health, Inc. | BioReference Laboratories

Bioreference.com OPKO Health BioReference Laboratories, Inc. is a wholly owned subsidiary of OPKO Health, Inc. Our diagnostics business includes BioReference Laboratories, the largest specialty laboratory with a core genetic testing business and a 400-person sales and marketing team to drive growth and leverage new products, including the 4Kscore® prostate ...

OPKO Health (OPK) to Report Q4 Earnings: What's in Store

Nasdaq.com Feb 15, 2021 · OPKO Health, Inc. OPK is scheduled to release fourth-quarter 2020 results on Feb 18, after the closing bell. In the last reported quarter, the company’s earnings matched the consensus mark.

OPKO Health Inc (OPK) Quote - XNAS | Morningstar

Morningstar.com Opko Health is a diversified biotechnology company that operates pharmaceutical and diagnostic development programs. Opko's diagnostics business includes a core genetic testing operation. It has a ...

The Chart for OPKO Health Inc. (OPK) Is Flashing Mixed

Newsheater.com Mar 02, 2021 · OPKO Health Inc. (NASDAQ:OPK) went up by 4.44% from its latest closing price compared to the recent 1-year high of $6.47. The company’s stock price has collected -0.63% of loss in the last five trading sessions. Press Release reported on 02/18/21 that OPKO Health Reports 2020 Fourth Quarter Business Highlights and Financial Results. Get the hottest stocks to trade every day …

Opko Health Inc (OPK) Stock Message Board - InvestorsHub

Investorshub.advfn.com Company Name: Opko Health Inc, Stock Symbol: OPK, Industry: Biotechs, Total Posts: 14894, Last Post: 4/14/2021 9:05:38 AM

OPK - Stock quote for OPKO HEALTH, INC. - MSN Money

Msn.com Apr 01, 2021 · OPKO Health, Inc. (NASDAQ:OPK) Has Fared Decently But Fundamentals Look Uncertain: What Lies Ahead For The Stock? Yahoo Finance 3/26/2021. Insider Buys OPKO Health…

Claim Form | Steinberg v. Opko Health, Inc.

Opkohealthsecuritieslitigation.com This is the OPKO Health Securities Settlement. Steinberg v. OPKO Health, Inc. OPKO Health Securities Litigation Case No. 1:18-cv-23786-MARTINEZ-OTAZO-REYES (S.D. Fla.) Home;

OPK: OPKO Health Inc - Stock Price, Quote and News - CNBC

Cnbc.com OPKO Health, Inc. is a healthcare company. Its segments include Pharmaceutical, Diagnostics and Corporate. Pharmaceutical consists of the pharmaceutical operations in Chile, Mexico, Ireland ...

OPKO Health (OPK) to Report Q3 Earnings: What's in Store

Nasdaq.com Oct 27, 2020 · OPKO Health, Inc. OPK is scheduled to release third-quarter 2020 results on Oct 29, after the closing bell. In the last reported quarter, the company delivered an earnings surprise of 171.4%.

OPK OPKO Health, Inc. Stock Quote - FINVIZ.com

Finviz.com OPKO Health, Inc., a healthcare company, engages in the diagnostics and pharmaceuticals businesses in the United States, Ireland, Chile, Spain, Israel, Mexico, and internationally. The company's Diagnostics segment operates BioReference Laboratories that offers laboratory testing services for the detection, diagnosis, evaluation, monitoring ...

Opko Health Inc (OPK) | Radically Better Financial

Wallmine.com OPKO Health's GeneDx Adds Repeat Expansion Analysis Genetic Tests for Diagnosis of Spinocerebellar Ataxia , Friedreich Ataxia, and Other Common Forms of Hereditary Ataxia. Thursday, 14 January 2021. yahoo. OPKO Health's BioReference Extends Digital Health Access.

OPK:Tel Aviv Stock Quote - OPKO Health Inc - Bloomberg Markets

Bloomberg.com OPKO Health, Inc. is involved in the discovery, development, and commercialization of pharmaceutical products, vaccines, and diagnostic products. Address. 4400 Biscayne Blvd Suite 1180 Miami, FL ...

Opko Health | OpkoDD

Opkodd.com General OpkoDD - Everything OPKO Health Inc. Opko Health. OPKO Strategic Investments. OPKO Licensee's & Partners. OPKO Health (OPK) Earnings. OPKO Government Contract Vehicles. Dr. Frosts Investments. Billionaire Dr. Phillip Frost, M.D. OPKO Related Videos & Audio. The Market. Futures . …

OPK.O - Opko Health Inc. Profile | Reuters

Reuters.com OPKO Health, Inc. is a healthcare company. Its segments include Pharmaceutical, Diagnostics and Corporate. Pharmaceutical consists of the pharmaceutical operations in Chile, Mexico, Ireland ...

OPKO Health, Inc. (NASDAQ:OPK) Expected to Post Quarterly

Marketbeat.com Mar 18, 2021 · Equities research analysts expect OPKO Health, Inc. (NASDAQ:OPK) to post $503.00 million in sales for the current fiscal quarter, according to Zacks. Three analysts have provided estimates for OPKO Health's earnings. The highest sales estimate is …

OPK | Stock Snapshot - Fidelity

Eresearch.fidelity.com Apr 13, 2021 · OPKO Health, Inc., a healthcare company, engages in the diagnostics and pharmaceuticals businesses in the United States, Ireland, Chile, Spain, Israel, Mexico, and internationally. The company's Diagnostics segment operates BioReference Laboratories that offers laboratory testing services for the detection, diagnosis, evaluation, monitoring ...

OPK:NASDAQ GS Stock Quote - OPKO Health Inc - Bloomberg

Bloomberg.com OPKO Health, Inc. is involved in the discovery, development, and commercialization of pharmaceutical products, vaccines, and diagnostic products. Address 4400 Biscayne Blvd Suite 1180 Miami, FL ...

OPK: Dividend Date & History for Opko Health Inc

Dividend.com Opko Health Inc. Estimates are provided for securities with at least 5 consecutive payouts, special dividends not included. For ETFs and Mutual Funds, return of capital and capital gains distributions are not included. If the last five payouts show limited variability, we …

Opko Health Inc (NYSE:OPK) - ROCE Insights For OPKO Health

Benzinga.com Feb 22, 2021 · Looking at Q4, OPKO Health (NASDAQ:OPK) earned $49.36 million, a 124.97% increase from the preceding quarter. OPKO Health also posted a total of $494.60 million in sales, a …

Opko Health - Overview, News & Competitors | ZoomInfo.com

Zoominfo.com BioReference Laboratories Expands Its Major League Sports Relationships with Addition of Major League Baseball ELMWOOD PARK, N.J., April 1, 2021 /PRNewswire/ -- BioReference Laboratories, Inc., an OPKO Health company (NASDAQ:OPK), today announced a COVID-19 testing agreement for players and staff, stadium employees and league staff for the 2021 Major League Baseball (MLB) season.

OPKO Health, Inc. | Bernstein Litowitz Berger & Grossmann LLP

Blbglaw.com In re OPKO Health, Inc. Securities Litigation. Court: United States District Court of the Southern District of Florida. Case Number: 1:18-cv-23786-JEM. Class Period: 09/26/2013 - 09/07/2018. Case Contacts: John Rizio-Hamilton, Jai K. Chandrasekhar, Adam Hollander, R. Ryan Dykhouse.

OPK OPKO Health, Inc. Stock Quote - FINVIZ.com

Finviz.com OPKO Health, Inc., a healthcare company, engages in the diagnostics and pharmaceuticals businesses in the United States, Ireland, Chile, Spain, Israel, Mexico, and internationally. The company's Diagnostics segment operates BioReference Laboratories, a clinical laboratory that offers laboratory testing services.